Literature DB >> 12624785

Analysis of the TP53 gene in laser-microdissected glioblastoma vasculature.

Andres Kulla1, Karim Burkhardt, Birgit Meyer-Puttlitz, Tambet Teesalu, Toomas Asser, Otmar D Wiestler, Albert J Becker.   

Abstract

Malignant transformation of human gliomas is accompanied by extensive proliferation of stromal blood vessels. Recent data suggest mesenchymal transdifferentiation of neoplastic cells in various human cancers, including colon and breast cancer as well as gliosarcoma. In this study, we have analyzed proliferating stromal blood vessels in glioblastoma multiforme for the presence of mutations in the tumor suppressor gene TP53. Using tissue arrays derived from glioblastoma specimens, cases with significant immunohistochemical p53 accumulation were selected for molecular genetic detection of TP53 mutations in exons 5 to 8. None of the tumors included in this series displayed properties of gliosarcoma. Proliferating glomeruloid stromal vessels were isolated by laser microdissection from paraffin sections. In six cases, single-strand conformation polymorphism analysis for mutations of the TP53 gene in stromal blood vessels compared with adjacent tumor cells and subsequent DNA sequencing of the resulting DNA fragments were carried out. Glioblastoma cells of these cases exhibited TP53 mutations in exons 5, 7 and 8. None of these tumors showed TP53 mutations in microdissected samples from glomeruloid vessels. The absence of TP53 mutations in vascular stromal components of glioblastoma multiforme supports the hypothesis that microvascular proliferations originate from the tumor stroma and are not derived from transdifferentiated glioblastoma cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12624785     DOI: 10.1007/s00401-003-0681-6

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  8 in total

1.  Multiscale modeling of glioblastoma.

Authors:  Huaming Yan; Mónica Romero-López; Lesly I Benitez; Kaijun Di; Hermann B Frieboes; Christopher C W Hughes; Daniela A Bota; John S Lowengrub
Journal:  Transl Cancer Res       Date:  2018-02       Impact factor: 1.241

2.  Glioblastoma: Defining Tumor Niches.

Authors:  Dolores Hambardzumyan; Gabriele Bergers
Journal:  Trends Cancer       Date:  2015-12

3.  Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth.

Authors:  Lin Cheng; Zhi Huang; Wenchao Zhou; Qiulian Wu; Shannon Donnola; James K Liu; Xiaoguang Fang; Andrew E Sloan; Yubin Mao; Justin D Lathia; Wang Min; Roger E McLendon; Jeremy N Rich; Shideng Bao
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

Review 4.  Cancer Stem Cells and Neovascularization.

Authors:  Fengkai Li; Jiahui Xu; Suling Liu
Journal:  Cells       Date:  2021-04-30       Impact factor: 6.600

Review 5.  Neoplastic cells are a rare component in human glioblastoma microvasculature.

Authors:  Fausto J Rodriguez; Brent A Orr; Keith L Ligon; Charles G Eberhart
Journal:  Oncotarget       Date:  2012-01

Review 6.  Tumor Endothelial Heterogeneity in Cancer Progression.

Authors:  Nako Maishi; Dorcas A Annan; Hiroshi Kikuchi; Yasuhiro Hida; Kyoko Hida
Journal:  Cancers (Basel)       Date:  2019-10-09       Impact factor: 6.639

Review 7.  Tumor angiogenesis: causes, consequences, challenges and opportunities.

Authors:  Roberta Lugano; Mohanraj Ramachandran; Anna Dimberg
Journal:  Cell Mol Life Sci       Date:  2019-11-06       Impact factor: 9.261

Review 8.  Tumor Endothelial Cell-A Biological Tool for Translational Cancer Research.

Authors:  Dorcas Akuba-Muhyia Annan; Hiroshi Kikuchi; Nako Maishi; Yasuhiro Hida; Kyoko Hida
Journal:  Int J Mol Sci       Date:  2020-05-03       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.